Wisdom News & Insights

Wisdom News brings you analysis of notable decisions from courts, legal reforms and updates in East Asia (Taiwan, China, Japan and Hong Kong etc). Please leave your email address here to subscribe to our newsletter and stay updated on the latest IP developments.

2024-09-20 The Court Overturns CNIPA’s Determination on the Written Description Requirement for Parameter Limits
Patents
2024-08-08 The Supreme People's Court of China’s Decision on the Requirements for Parameter Claims
Patents
2024-01-19 Invalidation of Compound “Upadacitinib” by CNIPA - Admissibility of Supplementary Experimental Data in China
Patents
2023-09-28 Amendment to Markush Claim in China and Takeaways
Patents
2023-08-17 The Taiwan FTC Imposed Fines on Companies Advertising Products Marked with Revoked Patent Numbers
Patents
2023-07-13 Trends on Recent Judgment of Parameter Claims in China
Patents
2023-03-09 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part IV
Patents
2023-02-24 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, U.S. and Europe Practice: Part III
Patents
2023-02-01 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part II
Patents
2023-01-13 Whether Erroneous Prior Art Disclosure Supports Obviousness--Comparison between Taiwan, China, US and Europe Practice: Part I
Patents
2023-01-04 When are Trademarks Deceptive? Comparing Food and Drug Trademarks in Taiwan and China
Trademarks
2022-12-02 PART II— Five Patent Invalidation Challenges- CSPC Succeeded in invalidating Mitsubishi Tanabe Pharma Corporation’s Novastan® HI injection 10 mg/2mL Patent
Patents
2022-10-25 PART I— Five Patent Invalidation Challenges- CSPC Succeeded in invalidating Mitsubishi Tanabe Pharma Corporation’s Novastan® HI injection 10 mg/2mL Patent
Patents
2022-08-31 Latest Judgement on Inventive Step of Semiconductor Patent: Dow Global Technologies and Rohm and Haas’s Equipment Patent Was Declared Invalid
Patents
2022-07-28 Top 10 Patent Cases of 2021 - Actelion’s OPSUMIT® Pharma Patent Survived the Invalidation
Patents
2022-06-09 Part III – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China
Patents
2022-05-03 Part II – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China
Patents
2022-04-27 Part I – How to Approach Non-Obviousness Requirement Examination for Chemical and Biopharma Patents in Europe, the United States, Taiwan, and China
Patents
2022-04-15 Part II - Strategies in Response to Non-Obviousness Requirements for Mechanical and Software Patents in the United States, China, Europe and Taiwan
Patents
2022-04-01 Revocation for Non-use of Taiwan and China Trademarks: Comparisons between Laws, Regulations and Practices
Trademarks
Cart

Login

Login Success